Spots Global Cancer Trial Database for cervical neoplasms
Every month we try and update this database with for cervical neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | NCT01523678 | Ovarian Cancer Endometrial Can... Uterine Cervica... | Filgrastim Paclitaxel Carboplatin | 18 Years - | Belgian Gynaecological Oncology Group | |
European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System | NCT01671462 | Uterine Cervica... | BD HPV assay on... | - | Becton, Dickinson and Company | |
Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients | NCT00950261 | Cervical Neopla... | tri-weekly cisp... | - | Korea Cancer Center Hospital | |
A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | NCT00190528 | Cervical Neopla... | neoadjuvant che... radical hystere... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients | NCT00950261 | Cervical Neopla... | tri-weekly cisp... | - | Korea Cancer Center Hospital | |
European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System | NCT01671462 | Uterine Cervica... | BD HPV assay on... | - | Becton, Dickinson and Company | |
Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer | NCT00916500 | CERVICAL NEOPLA... | CONCURRENT CHEM... | 20 Years - 75 Years | Korea Cancer Center Hospital | |
Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer | NCT04096911 | Uterine Cervica... Cervical Cancer Cervical Neopla... Cervix Cancer | Sintilimab quadrivalent HP... | 18 Years - | Northern Jiangsu People's Hospital | |
Epidemiological Landscape of Cervical Cancer in Latin America | NCT04947605 | Uterine Cervica... | 18 Years - | Latin American Cooperative Oncology Group | ||
A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | NCT00190528 | Cervical Neopla... | neoadjuvant che... radical hystere... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens | NCT02267876 | Cervical Neopla... Human Papilloma... | BD HPV Assay on... Colposcopy | 21 Years - | Becton, Dickinson and Company | |
Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial) | NCT01627288 | Cancer of the C... Cervical Neopla... | Boost radiation | 18 Years - | Duke University | |
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies | NCT04266093 | Cervical Intrae... Cervical Neopla... Oropharyngeal N... Squamous Intrae... Hematologic Mal... | GeneTherapy | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors | NCT05824494 | Uterine Cervica... Cancer of Cervi... Cervical Cancer Cervical Neopla... Uterine Cervica... Cancer of the U... | Cadonilimab Nab paclitaxel | 18 Years - 75 Years | Women's Hospital School Of Medicine Zhejiang University |